Volume 8, Number 4—April 2002
Research
Outcomes of Treated Human Granulocytic Ehrlichiosis Cases
Table 1
Recurrent or continuous symptoms experienced during the preceding 12 months by human granulocytic ehrlichiosis patients and controls, Wisconsin, 1999
Symptom | Patients (N=85) number (%) | Controls (N=102) number (%) | OR | 95% CI |
---|---|---|---|---|
Fevers | 12 (14.1) | 3 (2.9) | 5.4 | 1.7-24.4 |
Shaking chills | 16 (18.8) | 5 (4.9) | 4.5 | 1.7-14.3 |
Sweats | 31 (36.5) | 16 (15.7) | 3.1 | 1.6-6.3 |
Fatigue | 47 (55.3) | 38 (37.3) | 2.1 | 1.2-3.7 |
Confusion | 16 (18.8) | 12 (11.8) | 1.7 | 0.8-4.0 |
Muscle weakness | 27 (31.8) | 30 (29.4) | 1.1 | 0.6-2.1 |
Headache | 21 (24.7) | 13 (12.8) | 1.1 | 0.7-1.9 |
Muscle aches | 40 (47.1) | 44 (43.1) | 1.0 | 0.7-1.5 |
Joint pains | 50 (58.8) | 54 (52.9) | 0.9 | 0.6-1.2 |
Nausea | 14 (16.5) | 15 (14.7) | 0.8 | 0.5-1.4 |
OR = odds ratio; 95% CI = 95% confidence interval.